The use of adenoviral vectors in gene therapy and vaccine approaches
Abstract Adenovirus was first identified in the 1950s and since then this pathogenic group of viruses has been explored and transformed into a genetic transfer vehicle. Modification or deletion of few genes are necessary to transform it into a conditionally or non-replicative vector, creating a vers...
Principais autores: | Natália Meneses Araújo, Ileana Gabriela Sanchez Rubio, Nicholas Pietro Agulha Toneto, Mirian Galliote Morale, Rodrigo Esaki Tamura |
---|---|
Formato: | Artigo |
Idioma: | English |
Publicado em: |
Sociedade Brasileira de Genética
2022-10-01
|
coleção: | Genetics and Molecular Biology |
Assuntos: | |
Acesso em linha: | http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1415-47572022000400108&tlng=en |
Registros relacionados
-
Development of novel vaccine vectors: Chimpanzee adenoviral vectors
por: Jingao Guo, et al.
Publicado em: (2018-07-01) -
Factors Which Contribute to the Immunogenicity of Non-replicating Adenoviral Vectored Vaccines
por: Lynda Coughlan
Publicado em: (2020-05-01) -
Advances of Recombinant Adenoviral Vectors in Preclinical and Clinical Applications
por: Luca Scarsella, et al.
Publicado em: (2024-02-01) -
Improving adenoviral vectors and strategies for prostate cancer gene therapy
por: Rodrigo Esaki Tamura, et al.
Publicado em: (2018-08-01) -
DEVELOPMENT OF VACCINES BASED ON ADENOVIRAL VECTORS: A REVIEW OF FOREIGN CLINICAL STUDIES (PART 2)
por: L. V. Cherenova, et al.
Publicado em: (2017-08-01)